LEO, MARENZA
 Distribuzione geografica
Continente #
NA - Nord America 2.026
EU - Europa 907
AS - Asia 215
AF - Africa 60
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 3.218
Nazione #
US - Stati Uniti d'America 1.982
SE - Svezia 282
IT - Italia 185
CN - Cina 133
BG - Bulgaria 92
DE - Germania 88
AT - Austria 78
GB - Regno Unito 67
CA - Canada 42
FR - Francia 41
CI - Costa d'Avorio 38
VN - Vietnam 28
SN - Senegal 20
FI - Finlandia 19
BE - Belgio 18
SG - Singapore 18
IN - India 16
UA - Ucraina 16
TR - Turchia 15
RU - Federazione Russa 11
NL - Olanda 4
AU - Australia 3
EU - Europa 3
BR - Brasile 2
CH - Svizzera 2
HK - Hong Kong 2
PA - Panama 2
RO - Romania 2
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
ES - Italia 1
JP - Giappone 1
PK - Pakistan 1
PL - Polonia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.218
Città #
Fairfield 288
Woodbridge 286
Houston 263
Ann Arbor 234
Chandler 158
Seattle 122
Ashburn 109
Wilmington 103
Sofia 92
Cambridge 85
Vienna 68
Serra 66
Beijing 52
Abidjan 38
Ottawa 37
Princeton 37
London 33
Lawrence 31
Medford 29
Bremen 26
Nanjing 24
Des Moines 23
Lancaster 23
Florence 21
Dakar 20
Brussels 18
Dong Ket 18
Milan 16
Dearborn 15
Marseille 15
Frankfurt am Main 13
Nanchang 10
San Diego 10
Falls Church 9
Jacksonville 9
Hebei 8
Izmir 8
Chicago 7
Kunming 6
Pisa 6
Rome 6
Aosta 4
Changsha 4
Jüchen 4
Munich 4
Ossé 4
San Francisco 4
Singapore 4
Tianjin 4
Toronto 4
Boulder 3
Hangzhou 3
Jiaxing 3
Jinan 3
Ningbo 3
Redwood City 3
Washington 3
Abano Terme 2
Ankara 2
Bucharest 2
Canberra 2
Chengdu 2
Düsseldorf 2
Egg 2
Englewood 2
Guangzhou 2
Gurgaon 2
Hefei 2
Kocaeli 2
Los Angeles 2
New Delhi 2
New York 2
Northbrook 2
Panama City 2
Phoenix 2
Senigallia 2
Vertemate con Minoprio 2
Ambato 1
Auburn Hills 1
Boardman 1
Central District 1
Council Bluffs 1
Diss 1
Fuzhou 1
Grafing 1
Harran 1
Highland 1
Hyderabad 1
Islamabad 1
Kaohsiung 1
Lanzhou 1
Le Casine-Perignano-Spinelli 1
Lishui 1
Madrid 1
Mainz 1
Mascali 1
Melbourne 1
Norwalk 1
Palm City 1
Parma 1
Totale 2.562
Nome #
Natural history of graves’ orbitopathy after treatment 166
A 70-year-old woman with Bilateral Orbital Infiltrative disease. 155
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 149
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 145
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 138
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 132
null 121
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 111
Outcome of Graves’ Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 109
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 109
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 105
Dissecting the genetic susceptibility to graves' disease in a cohort of patients of Italian origin 105
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 103
Thyroid volume and severity of graves' orbitopathy 102
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 102
null 97
Treatment options for Graves' orbitopathy. 96
PREGO ( presentation of Graves' orbitopathy) study: Changes in referral patterns to European Group on Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 95
null 93
null 91
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 91
null 88
Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy 86
Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy 85
Combined mycophenolate + prednisolone therapy is more effective than prednisolone in active and moderate-to-severe Graves’ Orbitopathy – A randomized, observer blind, multicenter trial 77
Oxidative stress in graves' disease. 75
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 67
null 65
Hypothyroidism Due to L-T4 Withdrawal Can Precipitate Optic Neuropathy in Patients with Moderate to Severe Graves' Ophthalmopathy: Report on Two Cases 61
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 60
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 55
Selenium in Graves Hyperthyroidism and Orbitopathy 50
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 50
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 27
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy 22
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy 18
Total thyroid ablation in Graves' orbitopathy 2
Totale 3.303
Categoria #
all - tutte 6.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019358 0 0 0 2 8 9 63 6 24 52 99 95
2019/2020765 87 43 80 51 86 86 80 66 72 41 56 17
2020/2021286 14 19 19 30 30 10 19 29 26 31 20 39
2021/2022516 5 8 6 38 110 59 9 17 75 63 11 115
2022/2023659 64 119 54 51 46 67 14 58 120 3 49 14
2023/202487 30 24 33 0 0 0 0 0 0 0 0 0
Totale 3.303